HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: A cohort study in South African mineworkers

Lancet

Volumn 358, Issue 9294, 2001, Pages 1687-1693

  Sonnenberg, Pamela ^a   Murray, Jill ^b   Glynn, Judith R ^a   Shearer, Stuart ^c   Kambashi, Bupe ^d   Godfrey Faussett, Peter ^a,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c GOLD FIELDS LIMITED   (South Africa)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FINGERPRINTING; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG CAVITATION; MINER; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REINFECTION; RELAPSE; RISK FACTOR; SOUTH AFRICA; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0035904773     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06712-5     Document Type: Article

References (30)

1. Exogenous reinfection in tuberculosis
2. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease
3. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy
4. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India
5. Recurrent tuberculosis due to exogenous reinfection
6. Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe
7. Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: A countryside 9-year cohort study. Swiss HIV Cohort Study
8. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
9. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa
10. HIV and tuberculosis in rural sub-Saharan Africa: A cohort study with two year follow-up
11. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients
12. Pulmonary tuberculosis in HIV-infected patients in Zaire: A controlled trial of treatment for either 6 or 12 months
13. Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa
14. Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons
15. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: A randomised trial
16. Increased recurrence of tuberculosis in HIV-1-infected patients in KEN
17. The impact of HIV infection on recurrence of tuberculosis in South African gold miners
18. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire
19. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: Two-year follow-up of a cohort in Lusaka, Zambia
20. Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients
21. Tuberculosis control and molecular epidemiology in a South African gold-mining community
22. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology
23. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus
24. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
25. Factors affecting relapse following short-course chemotherapy
26. Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation
27. Factors influencing relapse in pulmonary tuberculosis: A statistical analysis of 1259 patients followed from eleven months to six years after discharge
28. Relapse in tuberculosis
29. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis
30. The effect of dosage cards on compliance with directly observed tuberculosis therapy in hospital